The Effects of Angiotensin Converting Enzyme Inhibitors (ACE-I) on Human N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (Ac-SDKP) Levels: A Systematic Review and Meta-Analysis

The Effects of Angiotensin Converting Enzyme Inhibitors (ACE-I) on Human N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (Ac-SDKP) Levels: A Systematic Review and Meta-Analysis

Bibliographic Details
Main Authors:	Mnguni, Ayanda Trevor, Engel, Mark E., Borkum, Megan S., Mayosi, Bongani M.
Format:	Online
Language:	English
Published:	Public Library of Science 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686106/

Similar Items

Acetylated α-Tubulin Regulated by N-Acetyl-Seryl-Aspartyl-Lysyl-Proline(Ac-SDKP) Exerts the Anti-fibrotic Effect in Rat Lung Fibrosis Induced by Silica
by: Xiaojun, Wang, et al.
Published: (2016)

N-acetyl-seryl-aspartyl-lysyl-proline Inhibits Diabetes-Associated Kidney Fibrosis and Endothelial-Mesenchymal Transition
by: Nagai, Takako, et al.
Published: (2014)

N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes
by: Kanasaki, Keizo, et al.
Published: (2014)

N-Acetyl-seryl-aspartyl-lysyl-proline Alleviates Renal Fibrosis Induced by Unilateral Ureteric Obstruction in BALB/C Mice
by: Chan, Gary C. W., et al.
Published: (2015)

Effect of Antifibrotic MicroRNAs Crosstalk on the Action of N-acetyl-seryl-aspartyl-lysyl-proline in Diabetes-related Kidney Fibrosis
by: Srivastava, Swayam Prakash, et al.
Published: (2016)

Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors
by: Kanasaki, Megumi, et al.
Published: (2011)

Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen
by: Nitta, Kyoko, et al.
Published: (2016)

Structural basis of Ac-SDKP hydrolysis by Angiotensin-I converting enzyme
by: Masuyer, Geoffrey, et al.
Published: (2015)

Usefulness of PKH fluorescent labelling to study leukemic cell proliferation with various cytostatic drugs or acetyl tetrapeptide – AcSDKP
by: Boutonnat, Jean, et al.
Published: (2005)

A Novel Angiotensin I-Converting Enzyme Mutation (S333W) Impairs N-Domain Enzymatic Cleavage of the Anti-Fibrotic Peptide, AcSDKP
by: Danilov, Sergei M., et al.
Published: (2014)

A New Antifibrotic Target of Ac-SDKP: Inhibition of Myofibroblast Differentiation in Rat Lung with Silicosis
by: Xu, Hong, et al.
Published: (2012)

Thymosin β4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis
by: Zuo, Yiqin, et al.
Published: (2013)

AcSDKP Regulates Cell Proliferation through the PI3KCA/Akt Signaling Pathway
by: Hu, Ping, et al.
Published: (2013)

Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis
by: Conte, Enrico, et al.
Published: (2016)

N-acetyl proline-glycine-proline: implications for neurological disorders
by: Hill, Jeff W., et al.
Published: (2016)

Angiotensin Converting Enzyme (ACE) and ACE2 Bind Integrins and ACE2 Regulates Integrin Signalling
by: Clarke, Nicola E., et al.
Published: (2012)

Matrix-derived inflammatory mediator N-acetyl proline-glycine-proline is neurotoxic and upregulated in brain after ischemic stroke
by: Hill, Jeff W., et al.
Published: (2015)

Lysine Acetylation Controls Local Protein Conformation by Influencing Proline Isomerization
by: Howe, Françoise S., et al.
Published: (2014)

Origin and evolution of lysyl oxidases
by: Grau-Bové, Xavier, et al.
Published: (2015)

Identification and characterisation of the angiotensin converting enzyme-3 (ACE3) gene: a novel mammalian homologue of ACE
by: Rella, Monika, et al.
Published: (2007)

Angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and circulating ACE levels are not associated with outcome in septic critically ill patients
by: Tsangaris, I, et al.
Published: (2011)

Angiotensin-Converting Enzyme (ACE) Gene Insertion/Deletion Polymorphism and ACE Inhibitor-Related Cough: A Meta-Analysis
by: Li, Ya-Feng, et al.
Published: (2012)

Characterization of aspartyl aminopeptidase from Toxoplasma gondii
by: Zheng, Jun, et al.
Published: (2016)

The angiotensin-converting enzyme (ACE) gene family of Anopheles gambiae
by: Burnham, Susan, et al.
Published: (2005)

ACE2 and Angiotensin-(1-7) in Hypertensive Renal Disease
by: Moon, Ju-Young
Published: (2011)

DNA Methylation Analysis of the Angiotensin Converting Enzyme (ACE) Gene in Major Depression
by: Zill, Peter, et al.
Published: (2012)

Use of ACE Inhibitors and Angiotensin Receptor Blockers and Primary Breast Cancer Outcomes
by: Chae, Young Kwang, et al.
Published: (2013)

Study of angiotensin converting enzyme (ACE) activity in patients with atherosclerosis and in healthy individuals.
by: GHolamreza Shahsavari, et al.
Published: (2018-06-01)

Angiotensin Converting Enzyme (ACE) Inhibitor Extends Caenorhabditis elegans Life Span
by: Kumar, Sandeep, et al.
Published: (2016)

Effect of Lysyl Oxidase Inhibition on Angiotensin II-Induced Arterial Hypertension, Remodeling, and Stiffness
by: Eberson, Lance S., et al.
Published: (2015)

Lysyl Oxidase Polymorphisms and Susceptibility to Osteosarcoma
by: Liu, Yang, et al.
Published: (2012)

Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease
by: Tikellis, Chris, et al.
Published: (2012)

New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) I: Endogenous Angiotensin Converting Enzyme (ACE) Inhibition
by: Fagyas, Miklós, et al.
Published: (2014)

New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) II: Albumin Suppresses Angiotensin Converting Enzyme (ACE) Activity in Human
by: Fagyas, Miklós, et al.
Published: (2014)

Angiotensin(1-7) and ACE2, “The Hot Spots” of Renin-Angiotensin System, Detected in the Human Aqueous Humor
by: Holappa, Mervi, et al.
Published: (2015)

Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors 1 and 2
by: Clayton, Daniel, et al.
Published: (2015)

Cardiomyopathies and myocardial disorders in Africa: present status and the way forward
by: Mayosi, Bongani M
Published: (2013)

The challenge of silent rheumatic heart disease
by: Bongani M Mayosi
Published: (2014-12-01)

Novel Natural Angiotensin Converting Enzyme (ACE)-Inhibitory Peptides Derived from Sea Cucumber-Modified Hydrolysates by Adding Exogenous Proline and a Study of Their Structure–Activity Relationship
by: Jianpeng Li, et al.
Published: (2018-08-01)

A new mutation in the gene encoding mitochondrial seryl-tRNA synthetase as a cause of HUPRA syndrome
by: Rivera, Henry, et al.
Published: (2013)